QCM
KURA icon

Quantinno Capital Management’s Kura Oncology KURA Stock Holding History

Quantinno Capital Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.27M Buy
206,728
+117,425
+131% +$1.11M ﹤0.01% 1875
2026
Q1 		$726K Buy
89,303
+50,498
+130% +$434K ﹤0.01% 2429
2025
Q4 		$403K Buy
38,805
+9,919
+34% +$104K ﹤0.01% 2630
2025
Q3 		$256K Buy
+28,886
New +$206K ﹤0.01% 2581
2025
Q2 		– Sell
-12,768
Closed -$84.3K – 2609
2025
Q1 		$84.3K Buy
+12,768
New +$99.5K ﹤0.01% 2058

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Quantinno Capital Management's KURA Position: Q2 2026 in Review

Quantinno Capital Management increased its Kura Oncology (KURA) stake by 131% in Q2 2026, buying an estimated $1.11M and bringing the position to 206,728 shares worth $2.27M. The position accounts for ﹤0.01% of the portfolio, ranked #1875.

Quantinno Capital Management first reported a position in KURA in Q1 2025 and has held it in 5 quarters since. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Quantinno Capital Management held 206,728 shares of Kura Oncology worth $2.27M as of Q2 2026.
  • Quantinno Capital Management bought 117,425 Kura Oncology shares in Q2 2026, an estimated $1.11M.
  • Kura Oncology made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #1875 holding.
  • Quantinno Capital Management first reported a position in Kura Oncology in Q1 2025 and has held it in 5 quarters since.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.